VIVEbiotech
San Sebastian
About VIVEbiotech
VIVEbiotech develops and manufactures lentiviral vectors in accordance with EMA and FDA guidelines. VIVEbiotech's lentiviral vectors are utilized to treat a variety of ailments, including haematological and solid malignancies, as well as uncommon diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: Less than $1M
- Total funding: $3.9M
- Funding stage: Private Equity
- Last round: Private Equity (Dec 2024)
- Website: vivebiotech.com
- Phone: +34 943 308 568
Industries & Categories
Biotechnology, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/vivebiotech-23902 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.